Poly Medicure Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1333
- Today's High:
- ₹1404.9
- Open Price:
- ₹1358.6
- 52W Low:
- ₹820.9
- 52W High:
- ₹1573.95
- Prev. Close:
- ₹1380.4
- Volume:
- 10343
Company Statistics
- Market Cap.:
- ₹133.87 billion
- Book Value:
- 129.418
- Revenue TTM:
- ₹11.87 billion
- Operating Margin TTM:
- 20.83%
- Gross Profit TTM:
- ₹4.68 billion
- Profit Margin:
- 18.11%
- Return on Assets TTM:
- 8.81%
- Return on Equity TTM:
- 15.4%
Company Profile
Poly Medicure Limited had its IPO on under the ticker symbol POLYMED.
The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Poly Medicure Limited has a staff strength of 0 employees.
Stock update
Shares of Poly Medicure Limited opened at ₹1358.6 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1333 - ₹1404.9, and closed at ₹1339.9.
This is a -2.93% slip from the previous day's closing price.
A total volume of 10,343 shares were traded at the close of the day’s session.
In the last one week, shares of Poly Medicure Limited have slipped by -4.08%.
Poly Medicure Limited's Key Ratios
Poly Medicure Limited has a market cap of ₹133.87 billion, indicating a price to book ratio of 7.7327 and a price to sales ratio of 8.734.
In the last 12-months Poly Medicure Limited’s revenue was ₹11.87 billion with a gross profit of ₹4.68 billion and an EBITDA of ₹3.06 billion. The EBITDA ratio measures Poly Medicure Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Poly Medicure Limited’s operating margin was 20.83% while its return on assets stood at 8.81% with a return of equity of 15.4%.
In Q1, Poly Medicure Limited’s quarterly earnings growth was a positive 132.4% while revenue growth was a positive 28.9%.
Poly Medicure Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 74.5326
- PEG
Its diluted EPS in the last 12-months stands at ₹18.72 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Poly Medicure Limited’s profitability.
Poly Medicure Limited stock is trading at a EV to sales ratio of 8.5256 and a EV to EBITDA ratio of 34.5616. Its price to sales ratio in the trailing 12-months stood at 8.734.
Poly Medicure Limited stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 11.16%.
Balance sheet and cash flow metrics
- Total Assets
- ₹15.77 billion
- Total Liabilities
- ₹2.93 billion
- Operating Cash Flow
- ₹0
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 11.16%
Poly Medicure Limited ended 2024 with ₹15.77 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹15.77 billion while shareholder equity stood at ₹12.42 billion.
Poly Medicure Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹2.93 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹285.81 million in goodwill. Its cash balance stood at ₹70.62 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹175.01 million.
Poly Medicure Limited’s total current assets stands at ₹8.07 billion while long-term investments were ₹0 and short-term investments were ₹3.02 billion. Its net receivables were ₹2.35 billion compared to accounts payable of ₹923.15 million and inventory worth ₹2.09 billion.
In 2024, Poly Medicure Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Poly Medicure Limited paid ₹0.11 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1339.9
- 52-Week High
- ₹1573.95
- 52-Week Low
- ₹820.9
- Analyst Target Price
- ₹
Poly Medicure Limited stock is currently trading at ₹1339.9 per share. It touched a 52-week high of ₹1573.95 and a 52-week low of ₹1573.95. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1292.11 and 200-day moving average was ₹1038.76 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 7111.3% of the company’s stock are held by insiders while 1733.6% are held by institutions.
Frequently Asked Questions About Poly Medicure Limited
Similar Industry Stocks (Medical Instruments & Supplies)
Most Active
Top Gainers
Top Losers
About
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal and tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. It offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. The company provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, universal caps, and ECG electrodes. The company was incorporated in 1995 and is based in New Delhi, India.